Bio-Techne Corporation
TECH
$62.30
-$1.52-2.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.85% | 5.23% | 4.72% | 4.46% | 2.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.85% | 5.23% | 4.72% | 4.46% | 2.41% |
| Cost of Revenue | 2.15% | 6.04% | 6.02% | 6.89% | 7.27% |
| Gross Profit | 4.72% | 4.82% | 4.08% | 3.27% | 0.11% |
| SG&A Expenses | 5.26% | 4.37% | 17.28% | 9.16% | 11.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.40% | 5.59% | 9.76% | 7.20% | 8.32% |
| Operating Income | 1.82% | 3.91% | -12.72% | -4.64% | -14.76% |
| Income Before Tax | -39.72% | -46.98% | -29.85% | -26.11% | -38.03% |
| Income Tax Expenses | 10.57% | 42.52% | 6.72% | 1.31% | -32.30% |
| Earnings from Continuing Operations | -48.26% | -56.34% | -35.14% | -29.45% | -38.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.26% | -56.34% | -35.14% | -29.45% | -38.91% |
| EBIT | 1.82% | 3.91% | -12.72% | -4.64% | -14.76% |
| EBITDA | -0.18% | 2.21% | -8.84% | -3.18% | -10.21% |
| EPS Basic | -48.17% | -56.71% | -35.34% | -29.62% | -39.02% |
| Normalized Basic EPS | 7.92% | 12.75% | -8.65% | -4.34% | -16.06% |
| EPS Diluted | -48.92% | -56.67% | -33.87% | -27.25% | -37.31% |
| Normalized Diluted EPS | 8.97% | 13.81% | -7.96% | -3.63% | -15.24% |
| Average Basic Shares Outstanding | -0.80% | -0.25% | 0.27% | 0.26% | 0.20% |
| Average Diluted Shares Outstanding | -1.66% | -1.04% | -0.48% | -0.41% | -0.76% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.92% | 1.29% | 0.55% | 0.42% | 0.64% |